4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-036712
Chief Medical Officer acquired 68,420 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bedrosian Camille L Chief Medical Officer | 2025-03-06 | Grant or award | +68,420 | 206,800 | D | ||
| Derivatives | |||||||
| Bedrosian Camille L Chief Medical Officer | 2025-03-06 | Grant or award · Stock Option (Right to Buy) | +102,630 | 102,630 | D | ||
Loading xslF345X05/ownership.xml…